AVALO THERAPEUTICS, INC. Operating Lease Right-of-Use Assets
AVALO THERAPEUTICS, INC. (AVTX) had Operating Lease Right-of-Use Assets of $198.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-08-06
- 2026-06-30: Operating Lease, Right-of-Use Asset $198.00K.
- 2026-03-31: Operating Lease, Right-of-Use Asset $268.00K.
- 2025-12-31: Operating Lease, Right-of-Use Asset $336.00K.
- 2025-09-30: Operating Lease, Right-of-Use Asset $402.00K.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-06-30 | $198.00K 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $268.00K 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $336.00K 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $402.00K 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $487.00K 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $615.00K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $741.00K 10-K · filed 2026-03-23 | |
| 2024-09-30 | $1.14M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $1.21M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $1.28M 10-Q/A · filed 2024-07-11 | |
| 2023-12-31 | $1.33M 10-K · filed 2025-03-20 | |
| 2023-09-30 | $1.39M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.46M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $1.68M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $1.75M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $1.81M 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $1.88M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $1.94M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $2.00M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $698.00K 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $773.00K 10-Q · filed 2021-08-02 | |
| 2021-03-31 | $846.00K 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $918.00K 10-K · filed 2022-03-02 | $917.47K 10-K · filed 2021-03-08 |
| 2020-09-30 | $983.41K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $1.06M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $710.23K 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $718.63K 10-K · filed 2021-03-08 | |
| 2019-09-30 | $719.11K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $728.14K 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $737.66K 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |